Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.7K
Overview
85.7K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SNORD50A/B disassemble ASC-1 complex to silence NF-κB and boost PD-1 blockade in non-small-cell lung cancer.

NPJ precision oncology·2026
Same author

Deep visual multi-omics reveals intra-tumor heterogeneity of gene expression and immunophenotype in colorectal cancer.

Science bulletin·2026
Same author

Epitaxy Beyond Periodic Lattices: Interfacial Modulation Enabled by Defect State 2D Materials.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

[Study on the diagnosis model of sepsis based on Medical Information Mart for Intensive Care-IV database].

Zhonghua wei zhong bing ji jiu yi xue·2026
Same author

Predictive Value of Machine Learning for Mortality Risk in Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2025
Same author

Correction to "Sericin Nerve Guidance Conduit Delivering Therapeutically Repurposed Clobetasol for Functional and Structural Regeneration of Transected Peripheral Nerves".

ACS biomaterials science & engineering·2025

Related Experiment Video

Updated: Mar 15, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.7K

KLRG1 restricts memory T cell antitumor immunity.

Lei Li1, Shanshan Wan2, Kaixiong Tao1

  • 1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Oncotarget
|August 25, 2016
PubMed
Summary

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) on T cells increases in tumors, impairing antitumor immunity. Repressing KLRG1 may offer novel cancer therapeutics by enhancing memory T cell function.

Keywords:
KLRG1antitumor immunitymemory T cellssenescence

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.4K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.7K
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.4K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Killer cell lectin-like receptor subfamily G member 1 (KLRG1) is expressed on human memory T lymphocytes.
  • The function of KLRG1 on human T cells, particularly within the tumor microenvironment, remains incompletely understood.

Purpose of the Study:

  • To investigate the role of KLRG1 expression on T cells in the tumor microenvironment.
  • To determine the functional characteristics of KLRG1-expressing T cells in cancer.

Main Methods:

  • Analysis of KLRG1 expression on T cells within the tumor microenvironment.
  • Assessment of proliferation, cytokine production, and transcription factor expression (Foxp3) in KLRG1+ T cells.
  • Evaluation of miRNA-101 and CtBP2 expression levels in KLRG1+ T cells.

Main Results:

  • KLRG1 expression on T cells is significantly elevated within the tumor microenvironment.
  • KLRG1+ T cells display reduced proliferative capacity and diminished effector cytokine production.
  • KLRG1+ T cells exhibit high Foxp3 expression and elevated levels of pro-inflammatory cytokines.
  • Decreased expression of miRNA-101 and increased expression of CtBP2 were observed in KLRG1+ T cells.

Conclusions:

  • KLRG1 expression on human memory T cells contributes to impaired antitumor immunity in the tumor microenvironment.
  • Targeting KLRG1 on T cells represents a potential therapeutic strategy for enhancing anti-cancer responses.